Ramipril Capsule
Product Images NDC 68180-591

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 68180-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 01

Chemical structure of ramipril, showing its molecular framework with various rings and functional groups characteristic of this antihypertensive drug.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 02

A line graph showing the proportion of patients over days of follow-up for Ramipril versus placebo groups. The y-axis represents the proportion of patients, ranging from 0.00 to 0.20, while the x-axis indicates days of follow-up up to about 1600 days. Two lines are plotted: a solid line for Ramipril and a dashed line for placebo. A statistically significant difference (P=0.0001) is noted between the groups.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 03

A forest plot chart showing the relative risk of a composite outcome in patients treated with Ramipril compared to a placebo group. The chart compares incidence across various subgroups including cardiovascular disease status, diabetes, age, sex, hypertension, history of coronary artery disease, prior myocardial infarction, cerebrovascular and peripheral vascular disease, and presence of microalbuminuria. Each subgroup lists the number of patients and incidence in the placebo group, with relative risk estimates and 95% confidence intervals represented visually.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 04

Label for Ramipril Capsules USP, 2.5 mg strength, oral capsule form. The label states each capsule contains 2.5 mg of ramipril USP. It is an Rx only product, packaged as 90 capsules. Manufactured by Lupin Limited, Goa, India, and labeled for Lupin Pharmaceuticals, Inc., Baltimore, Maryland. Storage instructions specify keeping the medication at 20° to 25°C (68° to 77°F) and dispensing in a light-resistant, child-resistant container.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 05

Label for Ramipril Capsules USP 5 mg by Lupin Pharmaceuticals, Inc. The label shows 90 oral capsules per container. It includes storage instructions at 20° to 25°C and child-resistant packaging warnings. Manufactured by Lupin Limited in India for Lupin Pharmaceuticals in Baltimore, Maryland.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 06

Ramipril Capsules USP 10 mg oral capsules label from Lupin Pharmaceuticals, Inc. The label shows the NDC 68180-591-09, states each capsule contains 10 mg of ramipril, and the package contains 90 capsules. Dosage, storage, pharmacist dispensing, and manufacturing details for Lupin Pharmaceuticals, Inc. are included.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 07

Ramipril Capsules USP 2.5 mg oral capsules, packaged 90 count. The label shows the active ingredient strength as 2.5 mg of ramipril per capsule. It is for prescription use only and manufactured by Lupin Limited in India for Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, USA. Storage instructions indicate controlled room temperature between 20° to 25°C (68° to 77°F).*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 08

Ramipril Capsules USP 5 mg oral capsules label from Lupin Pharmaceuticals, Inc. The label states each capsule contains 5 mg of ramipril. It specifies Rx only, package count of 90 capsules, and includes instructions for storage, warnings, and pharmacist dispensing requirements. Manufactured by Lupin Limited, India, and labeled for Lupin Pharmaceuticals, Inc. USA.*

FDA Label Image

9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 09

Ramipril Capsules USP 10 mg oral capsules label from Lupin Pharmaceuticals, Inc. The label states each capsule contains 10 mg of ramipril, indicates prescription use only, and package contains 90 capsules. It includes storage instructions between 20° to 25°C and warnings for proper handling and child safety. Manufactured by Lupin Limited in India and labeled for Lupin Pharmaceuticals, Inc. in Maryland, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.